Cargando…
Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539818/ https://www.ncbi.nlm.nih.gov/pubmed/34699970 http://dx.doi.org/10.1016/j.anai.2021.10.021 |
_version_ | 1784588838773981184 |
---|---|
author | Watts, Melissa M. Maurer, Laura E. Grammer, Leslie C. Saltoun, Carol A. Stevens, Whitney W. |
author_facet | Watts, Melissa M. Maurer, Laura E. Grammer, Leslie C. Saltoun, Carol A. Stevens, Whitney W. |
author_sort | Watts, Melissa M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8539818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85398182021-10-25 Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine Watts, Melissa M. Maurer, Laura E. Grammer, Leslie C. Saltoun, Carol A. Stevens, Whitney W. Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-02 2021-10-23 /pmc/articles/PMC8539818/ /pubmed/34699970 http://dx.doi.org/10.1016/j.anai.2021.10.021 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letters Watts, Melissa M. Maurer, Laura E. Grammer, Leslie C. Saltoun, Carol A. Stevens, Whitney W. Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine |
title | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine |
title_full | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine |
title_fullStr | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine |
title_full_unstemmed | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine |
title_short | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine |
title_sort | delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger rna vaccine |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539818/ https://www.ncbi.nlm.nih.gov/pubmed/34699970 http://dx.doi.org/10.1016/j.anai.2021.10.021 |
work_keys_str_mv | AT wattsmelissam delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine AT maurerlaurae delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine AT grammerlesliec delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine AT saltouncarola delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine AT stevenswhitneyw delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine |